Safety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid Tumours | MicrobiomeTrials
Safety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid Tumours
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2021-12-10Est. Completion: 2024-10-07
Enrollment target: 126 participants
Locations
Research Site, La Jolla, California, United States
Research Site, Los Angeles, California, United States
Research Site, Orange, California, United States
Research Site, Ventura, California, United States
Research Site, Atlanta, Georgia, United States
Research Site, Coeur d'Alene, Idaho, United States
Research Site, Boston, Massachusetts, United States
Research Site, Ann Arbor, Michigan, United States
Research Site, Grand Rapids, Michigan, United States
Research Site, Buffalo, New York, United States
Research Site, New York, New York, United States
Research Site, Portland, Oregon, United States
Research Site, San Antonio, Texas, United States
Research Site, Charlottesville, Virginia, United States
Research Site, Seattle, Washington, United States
Research Site, Madison, Wisconsin, United States
Research Site, Barrie, Ontario, Canada
Research Site, Toronto, Ontario, Canada
Other microbiome trials you might be interested in